iTeos Therapeutics Inc. - Topline interim dataset from GALAXIES Lung-201 with >240 patients anticipated in 2Q25 - Interim datasets from...
Reports
Gross profit increased 16.1% in 2024 compared to 2023 Building a robust AI technology foundation to drive solution development in...
Phase 2b study completed in amyotrophic lateral sclerosis (ALS) demonstrated lead asset PrimeC slows disease progression and functional decline Ongoing...
Generated $193 million in constant currency in the third quarter; strategic initiatives and SKU rationalization impacted revenue by $13 millionTilray...
March 31, 2025 4:00 PM EDT | Source: Phio Pharmaceuticals Corp. Continues advancing clinical trial for INSTASYL siRNA lead...
CAPE CANAVERAL, Fla., March 31, 2025--(BUSINESS WIRE)--Sidus Space (NASDAQ: SIDU) (the "Company" or "Sidus"), an innovative, agile space mission enabler,...
